GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » PEG Ratio

NKY Medical Holdings (SZSE:300109) PEG Ratio : 0.70 (As of May. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, NKY Medical Holdings's PE Ratio without NRI is 14.17. NKY Medical Holdings's 5-Year EBITDA growth rate is 20.30%. Therefore, NKY Medical Holdings's PEG Ratio for today is 0.70.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for NKY Medical Holdings's PEG Ratio or its related term are showing as below:

SZSE:300109' s PEG Ratio Range Over the Past 10 Years
Min: 0.39   Med: 2.63   Max: 3637.43
Current: 0.7


During the past 13 years, NKY Medical Holdings's highest PEG Ratio was 3637.43. The lowest was 0.39. And the median was 2.63.


SZSE:300109's PEG Ratio is ranked better than
82.93% of 369 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs SZSE:300109: 0.70

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


NKY Medical Holdings PEG Ratio Historical Data

The historical data trend for NKY Medical Holdings's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings PEG Ratio Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.57 18.57 198.54 2.54 0.51

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 1.14 0.75 0.51 0.45

Competitive Comparison of NKY Medical Holdings's PEG Ratio

For the Drug Manufacturers - General subindustry, NKY Medical Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NKY Medical Holdings's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NKY Medical Holdings's PEG Ratio distribution charts can be found below:

* The bar in red indicates where NKY Medical Holdings's PEG Ratio falls into.



NKY Medical Holdings PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

NKY Medical Holdings's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=14.170375079466/20.30
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


NKY Medical Holdings  (SZSE:300109) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


NKY Medical Holdings PEG Ratio Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines